The stock's fall snapped a four-day winning streak.
Fintel on MSN4d
Oppenheimer Initiates Coverage of Abbott Laboratories (ABT) with Outperform RecommendationFintel reports that on October 8, 2024, Oppenheimer initiated coverage of Abbott Laboratories (NYSE:ABT) with a Outperform ...
Somerset Trust Co lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% in the 3rd quarter, ...
Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
Hosted on MSN11d
Abbott's Quarterly Earnings Preview: What You Need to KnowBased in Abbott Park, Illinois, Abbott Laboratories (ABT) is a global healthcare company that develops a broad range of ...
Mattson Financial Services LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.7% in the 3rd quarter, ...
Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
On Friday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $112.43 which represents a decrease of $-0.30 or -0.27% from the prior close of $112.73. The stock opened at $112.93 and ...
Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE: ABT) with an Outperform rating and a price ...
Abbott Laboratories reported it achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback